32 for GSE17538 ) and tumor stage (HR 2.210, 95% CI: 1.609–3.035, p < 0.0001 for the discovery dataset; HR 2.398, 95% CI: 1.749–3.287, p < 0.0001 for GSE39582 ; HR 3.455, 95% CI: 1.893–6.304, p = 0.0001 for GSE 14333; HR 1.650, 95% CI: 0.959–2.836, p = 0.070 for GSE17538 ) maintained significant or marginally significant correlation with RFS in four datasets ( Table 2 ).
← all excerpts
Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon Cancer.
1
—
—